Positive results from both Phase 3 trials (VEGA-2 and VEGA-3) support future FDA application for Phentolamine Ophthalmic Solution 0.75%, potentially leading to market access and revenue generation.

RAPIDe-3, a pivotal global Phase 3 study evaluating deucrictibant immediate-release capsule (20 mg) for the on-demand treatment of HAE attacks in adults and adolescents (12 years and older ...

Guidance clarity improved, with Phase 3 trials for VK2735 now scheduled for Q2 2025, compared to broader timelines shared in Q3. Clinical focus shifted slightly towards long-term strategies, ...

About TROPION-Lung14 TROPION-Lung14 is a global, randomized, multicenter, open-label phase 3 trial evaluating the efficacy and safety of datopotamab deruxtecan (6.0 mg/kg) in combination with ...

In this phase 3, double-blind, randomized, placebo-controlled trial, we enrolled participants with myasthenia gravis who had anti–acetylcholine receptor antibodies or anti–muscle-specific ...

In this phase 3 trial of a treatment for giant-cell arteritis, upadacitinib at a dose of 15 mg once daily in combination with a 26-week glucocorticoid taper showed superior glucocorticoid-free ...